Ligand decorated biodegradable nanomedicine in the treatment of cancer
Author | Ejaj, Ahmad |
Author | Ali, Asgar |
Author | Fatima, Munazza Tamkeen |
Author | Nimisha |
Author | Apurva |
Author | Kumar, Arun |
Author | Sumi, Mamta P. |
Author | Sattar, Real Sumayya Abdul |
Author | Mahajan, Bhawna |
Author | Saluja, Sundeep Singh |
Available date | 2023-09-05T08:39:25Z |
Publication Date | 2021-05-31 |
Publication Name | Pharmacological Research |
Identifier | http://dx.doi.org/10.1016/j.phrs.2021.105544 |
Citation | Ahmad, E., Ali, A., Fatima, M. T., Kumar, A., Sumi, M. P., Sattar, R. S. A., ... & Saluja, S. S. (2021). Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research, 167, 105544. |
ISSN | 10436618 |
Abstract | Cancer is one of the major global health problems, responsible for the second-highest number of deaths. The genetic and epigenetic changes in the oncogenes or tumor suppressor genes alter the regulatory pathways leading to its onset and progression. Conventional methods are used in appropriate combinations for the treatment. Surgery effectively treats localized tumors; however, it fails to treat metastatic tumors, leading to a spread in other organs, causing a high recurrence rate and death. Among the different strategies, the nanocarriers-based approach is highly sought for, but its nonspecific delivery can cause a profound side effect on healthy cells. Targeted nanomedicine has the advantage of targeting cancer cells specifically by interacting with the receptors overexpressed on their surface, overcoming its non-specificity to target healthy cells. Nanocarriers prepared from biodegradable and biocompatible materials are decorated with different ligands by encapsulating therapeutic or diagnostic agents or both to target cancer cells overexpressing the receptors. Scientists are now utilizing a theranostic approach to simultaneously evaluate nanocarrier bio-distribution and its effect on the treatment regime. Herein, we have summarized the recent 5-year efforts in the development of the ligands decorated biodegradable nanocarriers, as a targeted nanomedicine approach, which has been highly promising in the treatment of cancer. |
Language | en |
Publisher | Elsevier |
Subject | Hyaluronic Acid Biodegradable nanocarriers Transferrin Phospholipids CD44 |
Type | Article |
Volume Number | 167 |
Check access options
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Pharmacy Research [1261 items ]